2023
A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States
Liapakis A, Agbim U, Bittermann T, Dew M, Deng Y, Gan G, Emre S, Hunt H, Olthoff K, Locke J, Jesse M, Kumar V, Pillai A, Verna E, Lentine K, Group T. A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation 2023, 37: e14967. PMID: 36938716, DOI: 10.1111/ctr.14967.Peer-Reviewed Original ResearchMeSH KeywordsAttitudeDonor SelectionHumansLiver TransplantationLiving DonorsSurveys and QuestionnairesTreatment OutcomeUnited StatesConceptsDonor liver transplantDonor liver transplantationLiver transplant centersGood first optionLDLT centersLiver transplantLiver transplantationWaitlist candidatesTransplant centersDonor factorsLDLTTransplant providersConsensus conferenceSurgical expertiseElectronic surveyAmerican SocietyImportant barriersFirst optionExclusion rateKey barriersHigh levelsTransplantationTransplantFacilitatorsCenter
2022
Evaluating clinical effectiveness of SARS‐CoV‐2 vaccine in solid organ transplant recipients: A propensity score matched analysis
Tucker M, Azar MM, Cohen E, Gan G, Deng Y, Palacios C, Malinis M. Evaluating clinical effectiveness of SARS‐CoV‐2 vaccine in solid organ transplant recipients: A propensity score matched analysis. Transplant Infectious Disease 2022, 24: e13876. PMID: 35684932, PMCID: PMC9348300, DOI: 10.1111/tid.13876.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsSARS-CoV-2 infectionOrgan transplant recipientsCritical COVID-19Clinical effectivenessTransplant recipientsVaccine eraVaccinated solid organ transplant recipientsCOVID-19Propensity score-matched cohortSARS-CoV-2 vaccinationSevere coronavirus disease 2019Cause-specific Cox regression modelsCOVID-19-related mortalitySARS-CoV-2 vaccinesSARS-CoV-2 infection ratesCurrent vaccine recommendationsKey preventative strategiesPrimary vaccine seriesRetrospective cohort studyDoses of mRNACox regression modelCoronavirus disease 2019Poisson regression modelsVaccine series
2019
HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD, Antala S, Bow L, Sese D, Morotti R, Rodriguez-Davalos M, Gan G, Deng Y, Emre SH. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort. Experimental And Clinical Transplantation 2019, 17: 6-17. PMID: 30777518, PMCID: PMC11165937, DOI: 10.6002/ect.mesot2018.l30.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge FactorsChildChild, PreschoolConnecticutFemaleGraft RejectionGraft SurvivalHistocompatibilityHistocompatibility TestingHLA AntigensHumansImmunosuppressive AgentsInfantIsoantibodiesLiver TransplantationMaleRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeYoung AdultConceptsDonor-specific antibodiesEpitope mismatchesMismatch loadAcute rejectionClass II donor-specific antibodiesDQ lociDQ Donor-Specific AntibodiesNon-HLA antibodiesAntibody-mediated rejectionPediatric liver transplantationSingle-center cohortHLAMatchmaker softwareImmunosuppression strategiesLiver transplantLiver transplantationAllograft fibrosisEplet mismatchesLiver biopsyPediatric patientsFibrosis scoreHLA-DRRetrospective reviewTransplant physiciansHLA-DQHLA-DQB1